CD8A and nonpapillary renal cell carcinoma: Among ccRCC patients, we found the scores of CIBERSORT.CD8 and gene.CD8 in “Tumor-infiltrating lymphocyte (TIL)” category showed significant correlations with clinical response, achieving the best performance superior to the other biomarkers.